pembrolizumab
merck
[]
dr. ashwin somasundaram of and sponsor investigator of hcrn gi15-225 presents his abstract during poster session b #gi23 "a study of pembrolizumab in combination with y90 radioembolization in patients with poor prognosis hepatocellular carcinoma." 
An independent nonprofit cancer research organization conducting multi-center investigator-initiated oncology studies since 1984.